- freely available
J. Cardiovasc. Dev. Dis. 2014, 1(1), 121-133; doi:10.3390/jcdd1010121
Published: 21 May 2014
Abstract: 3'-5'-cyclic adenosine monophosphate (cAMP) is a second messenger, which plays an important role in the heart. It is generated in response to activation of G-protein-coupled receptors (GPCRs). Initially, it was thought that protein kinase A (PKA) exclusively mediates cAMP-induced cellular responses such as an increase in cardiac contractility, relaxation, and heart rate. With the identification of the exchange factor directly activated by cAMP (EPAC) and hyperpolarizing cyclic nucleotide-gated (HCN) channels as cAMP effector proteins it became clear that a protein network is involved in cAMP signaling. The Popeye domain containing (Popdc) genes encode yet another family of cAMP-binding proteins, which are prominently expressed in the heart. Loss-of-function mutations in mice are associated with cardiac arrhythmia and impaired skeletal muscle regeneration. Interestingly, the cardiac phenotype, which is present in both, Popdc1 and Popdc2 null mutants, is characterized by a stress-induced sinus bradycardia, suggesting that Popdc proteins participate in cAMP signaling in the sinuatrial node. The identification of the two-pore channel TREK-1 and Caveolin 3 as Popdc-interacting proteins represents a first step into understanding the mechanisms of heart rate modulation triggered by Popdc proteins.
The second messenger cyclic adenosine 3', 5' monophosphate (cAMP) plays a prominent role in cardiac physiology and signal transduction. cAMP is produced by adenylate cyclase (AC). There are ten different AC, nine of which are membrane-bound (AC1-9) and activated by G protein-coupled receptors (GPCRs) or by Ca2+ (Figure 1) . The tenth AC is soluble (sAC) and is regulated by bicarbonate . AC5 and -6 are the major isoforms present in cardiac myocytes and are coupled for example to adrenergic and cholinergic receptors through stimulatory and inhibitory Gα-subunits. Once activated, AC produces a large amount of cAMP, which passively diffuses in cells. cAMP is rapidly degraded by phosphodiesterases, which thereby ensure that cAMP diffusion is limited and usually confined to a small area around the site of production. There are three cAMP effector protein classes known: protein kinase A (PKA), exchange factor directly activated by cAMP (EPAC), and cyclic nucleotide-activated ion channels, which includes cyclic nucleotide–gated (CNG) channels, mainly expressed in photoreceptors and olfactory sensory neurons, and hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which are expressed in heart and brain . We recently discovered a fourth class of cAMP-binding proteins, the Popeye domain containing proteins (Popdc), which are the main focus of this review article [4,5,6,7]. A fifth potential cAMP-binding protein, Cris was recently identified, which however is exclusively expressed in sperm precursor cells .
2. The Popeye Domain Containing Proteins
The Popeye domain containing (Popdc) genes were discovered 15 years ago after screening cardiac cDNA libraries with the goal to identify genes with a cardiac-enriched expression pattern [9,10]. Immunohistochemistry, in situ hybridization, LacZ staining of knock-in reporter genes and RT-PCR established an exclusive expression in cardiac myocytes [4,10,11,12,13]. This expression pattern is evolutionary conserved [14,15,16].
There are three Popdc genes in vertebrates, Popdc1 (also known as Bves), Popdc2 and Popdc3 . Popdc genes encode small membrane-localized proteins, which are between 290–360 amino acids long. They have three transmembrane domains and in the cytoplasmic part of the protein, a highly conserved Popeye domain is present . Popdc proteins are unique and do not resemble any other non-Popdc protein. The proteins with the highest sequence similarity are the bacterial cAMP regulator proteins (CRP) , which encode transcription factors that modulate gene expression in response to metabolic changes . While a transcriptional regulatory role has yet to be demonstrated for Popdc proteins, both Popdc1 and Popdc2 have been found in the nucleus of striated muscle cells in addition to their presence at the plasma membrane .
The Popeye domain displays significant structural homology to cAMP-binding proteins . A homology model was devised and is based on structural information of CRP and PKA. This model revealed that a large fraction of invariant amino acids cluster around the putative cAMP-binding domain suggesting their involvement in nucleotide binding [4,6,7]. Indeed, for a number of these conserved residues, mutagenesis revealed an essential function in cAMP-binding. In particular, the aspartate residues D200 in Popdc1 and D184 in Popdc2 appear to be essential for nucleotide binding [4,6,7]. Surprisingly the protein sequence of the phosphate-binding cassette (PBC) is unique and different from that of HCN4, EPAC, or PKA [6,7]. This suggests an independent evolution of the PBC of Popdc proteins. Surprisingly, the PBC of Popdc proteins found in basic metazoans such as cniderians (Hydra) is almost identical to the PBC found in Popdc proteins from higher vertebrates  demonstrating strong evolutionary pressure to retain these sequences and providing further evidence for their functional importance. Affinity measurements revealed that Popdc proteins bind cyclic nucleotides with high affinity in the physiologically relevant range .
3. Loss-of-Function Mutations of Popeye Domain Containing Genes are Causing Cardiac Arrhythmia
All three members of the Popdc family are abundantly expressed in cardiac and skeletal muscle. Loss-of-function experiments in zebrafish using morpholino-mediated knockdown caused defective development of skeletal muscle in the head and trunk . While muscle development is apparently normal in mice, there is a retarded ability of skeletal muscle regeneration . In the zebrafish heart of popdc2 morphants, a severe atrioventricular block is observed . Interestingly, a cardiac arrhythmia phenotype is also found in mutant mice. In both Popdc1 and Popdc2 null mutants in mice, a bradyarrhythmia phenotype has been described . While at baseline no difference is present between mutant and wildtype, subjecting null mutants to physical or mental stress caused sinus pauses, which randomly occurred but were strictly stress-dependent . Moreover, for both Popdc1 and -2 mutants, phenotype development is age-dependent. Young mutants (3 months old) display a normal chronotropic competence, while middle-aged mutant mice (6–8 months old) are severely bradycardic . The age-dependency of the stress-induced bradycardia phenotype in these mouse mutants is reminiscent of sinus node dysfunction (SND) in man. SND is a leading cause for pacemaker implantation and patients with SND, which is prevalent in the elderly, have difficulties to adapt the beating frequency of their heart to the physiological demands . It has therefore been hypothesized that some SND patients may have abnormal Popdc gene expression or function . Although such data are presently unavailable, in failing hearts, the expression levels of POPDC1 and POPDC3 are reduced, however, the degree of down-regulation varies between patients . Reduced levels of POPDC1 and POPDC3 might represent risk factors for the development of sudden cardiac death, atrial fibrillation and other conduction disorders, which are prevalent among heart failure patients.
4. Protein-Protein Interactions of Popdc Proteins
Our understanding of the molecular function of Popdc proteins is currently limited due to the fact that we do not know the protein interaction partners of Popdc proteins. However, two relevant interacting proteins have now been identified.
It has been reported that Popdc proteins interact with the two-pore domain potassium channel TREK-1 . This background channel is regulated by a number of physiological stimuli . In the heart, TREK-1 is believed to act as a stretch sensor, which possibly modulates atrial natriuretic peptide (ANP) secretion . Trek-1 null mutants in mice have a normal lifespan, and no obvious morphological or physiological pathology in the heart was reported . Using Xenopus oocytes as a heterologous expression system, TREK-1 has been identified as a specific interaction partner of Popdc1 . Co-expression of both Popdc1 and TREK-1 results in a current, which is approximately 2-fold higher than without Popdc1 and probably is caused by an increased membrane presence of TREK-1. It is therefore plausible that Popdc proteins modulate TREK-1 trafficking. Importantly, in the presence of theophylline, which increases cAMP levels, the effect of Popdc co-expression is abolished and no increase in TREK-1 conductivity was observed . Based on the fact that TREK-1 current is enhanced in the presence of Popdc1, the null mutant should have a lower level of membrane-localized TREK-1. Since TREK-1 acts as a background channel setting the resting membrane potential, a reduction of TREK-1 current should lead to a situation in which myocytes would be more excitable, however the opposite is observed in the null mutant. Therefore it is likely that also the trafficking of other ion channels should depend on the interaction with Popdc proteins and defining these interactions might give a clue why Popdc1 and -2 mutants develop a stress-induced bradycardia phenotype.
Caveolae are invaginations of the plasma membrane, which are involved in compartmentalization and cluster formation of membrane proteins and thereby improving signal transduction . Important protein components of caveolae are cavins and caveolins . Caveolin-3 (Cav-3) is the muscle-specific isoform, which localizes to the sarcolemma in skeletal muscle fibers and in the plasma membrane and t-tubules in cardiac myocytes . Caveolae play various physiological roles, e.g., in vesicular trafficking, mechanosensation and transduction, and in signaling processes such as β- adrenergic signaling, and therefore in the control of cAMP production . A number of different ion channels and transporters have been localized to caveolae in cardiac myocytes including LTCC, SCN5A, HCN4, NCX1, and others .
Cav-3 has recently been identified as an interaction partner of Popdc1 . In the absence of Popdc1, caveolae in cardiac myocytes were altered in number and size. These alterations might contribute to the observed ischaemia/reperfusion vulnerability of Popdc1-null mutant hearts, but may also explain in part the cardiac arrhythmia phenotypes in Popdc1 and -2 mutants . In this regard, it is noteworthy that Cav-3 was also found to be an interaction partner for CaV1.2 and that caveolae in cardiac myocytes foster cluster formation of CaV1.2 and the β2-AR, PKA and AC, thus allowing compartmentalized cAMP production and signal transduction . It is therefore possible that Popdc proteins, being an interaction partner of Cav-3, are part of this signaling complex. In support of this notion it was found that isolated cardiac myocytes of Popdc1 mutants display a reduction in [Ca2+]i transients .
5. The Other cAMP Effector Proteins
5.1. Protein Kinase A (PKA)
PKA is the main effector of cAMP signaling. In its inactive form PKA is a tetramer composed of two regulatory (R) and two catalytic (C) subunits. There are four genes encoding regulatory subunits (RIα, RIβ, RIIα and RIIβ) and three genes encoding catalytic subunits (Cα, Cβ and Cγ). In the absence of cAMP, a dimer of C subunits are bound and suppressed by two R subunits . cAMP binds to the R subunits causing a conformational change that relieves the inhibitory effect on the C subunits allowing phosphorylation of PKA targets. In the heart, PKA regulates excitation-contraction coupling through the phosphorylation of a number of key proteins such as troponin I, ryanodine receptor (RyR), phospholamban (PLB) and L-type calcium channels (LTCCs) causing an increase in the force (inotropy) and frequency (chronotropy) of the heartbeat and an increase in cardiac relaxation (lusitropy) . SAN pacemaking is triggered by the rhythmic release of calcium from the sarcoplasmatic reticulum (SR) via the RyR, which is coupled to sarcolemmal currents capable of generating periodic action potentials . SAN cells have high basal levels of cAMP and display elevated PKA-dependent phosphorylation of phospholamban (PLB) compared with other cardiac cell types . In addition, PKA also triggers changes in gene expression through phosphorylation of nuclear target proteins such as CREB and HDAC4 and -5 [34,35,36]. Activation of PKA is compartmentalized due to recruitment of PKA to scaffolding proteins (AKAP), which anchor PKA close to its phosphorylation targets . Apart from PKA, AKAP proteins bind AC, PDE, protein phosphatases, GPCRs and even other cAMP effector proteins and therefore generate macromolecular signaling complexes .
5.2. The Exchange Factor Directly Activated by cAMP (EPAC)
The Exchange Factor Directly Activated by cAMP (Epac) is encoded by two distinct genes Rapgef3 (Epac1) and Rapgef4 (Epac2) . EPAC proteins are multi-domain proteins, which contain an N-terminal regulatory and a C-terminal catalytic region [40,41]. The regulatory region contains a high-affinity cAMP-binding domain, while the catalytic region entails a putative guanine nucleotide exchange factor (GEF) domain for both Rap1 and Rap2. Studies in neonatal rat cardiac myocytes show that an EPAC-selective cAMP agonist (8-pCPT-2'-O-Me-cAMP, 8-CPT) induces an increase in spontaneous Ca2+-oscillations , while in the adult mouse heart ventricular arrhythmia are triggered . The 8-CPT-induced increase in Ca2+ spark frequency is caused by Ca2+/calmodulin-dependent protein kinase II (CaMKII)-dependent phosphorylation of the RyR . Interestingly, the SR Ca2+-leak is triggered by EPAC-2 activation, suggesting isoform-specific roles in myocytes . EPAC activation also enhances cell-cell coupling between myocytes through gap junction formation . Another aspect of EPAC function is its role in cardiac hypertrophy. 8-CPT treatment or forced expression of EPAC-1 causes an increase in cell surface area, protein synthesis, and ANF expression and these effects were reversed by shRNA-mediated knockdown of Epac1 . Hypertrophy-inducing Epac1 signaling involves small GTPases, phospholipase C (PLC), calcineurin and CaMKII, which activate nuclear factor of activated T-cells (NFAT) and myocyte enhancer factor 2 (MEF2) .
5.3. The Hyperpolarization-Activated Cyclic Nucleotide-Gated (HCN) Channels
The HCN channels are essential components of cardiac pacemaking in sinuatrial cells and the encoded proteins are responsible for a cation current known as If . A unique property of If is the activation at a hyperpolarized membrane potential and it is therefore thought that If contributes to the pacemaker potential . However there is an emerging consensus that a network of ion channels and ion pumps at the plasma membrane and in the sarcoplasmatic reticulum act together to generate the oscillating pacemaker action potential .
Of the four HCN channels present in the mammalian genome, three channels (HCN1, HCN2 and HCN4) are expressed in the heart . While mutant mice for HCN2 have a relatively mild sinus dysrhythmia , both HCN1 and HCN4 null mutants display defective cardiac pacemaking [53,54,55]. Loss of HCN4 causes embryonic lethality due to a severe bradycardia , while the HCN1 null mutant has a postnatal sinus bradycardia . Consistent with the role of HCN channels in cardiac pacemaking is the observation that the If antagonist ivabradine, which binds HCN channels in its closed state , reduces heart rate in heart failure patients . Modeling and biophysical measurements have clearly established that cAMP-binding enhances channel opening  and therefore this property would be the ideal mechanism for triggering the chronotropic response after adrenergic stimulation. However, a number of reports in the literature demonstrate that pacemaking in adult mice harboring cAMP-binding site mutations in HCN4 retain the ability to respond to sympathetic stimulation, while embryonic hearts can only accelerate heart rate in the presence of a functional cAMP-binding site in HCN4 [60,61]. Data in patients either support , or refuse a role of If in the autonomous control of pacemaking . There is also evidence that HCN4 is a PKA substrate and that inhibition of PKA significantly reduces the ability of beta-adrenergic agonists to shift the voltage dependence of If in isolated sinuatrial myocytes . Thus, it is gradually emerging that different elements of the cAMP signal transduction pathway in sinuatrial myocytes act in parallel to mediate the adrenergic control of cardiac pacemaking.
The Popdc gene family is associated with cAMP signaling and therefore is part of the network of cAMP effector proteins. HCN channels and Popdc proteins display tissue-specific expression in the heart, while the other two cAMP effector proteins are more widely expressed. In particular the various elements of the cardiac conduction system display high-level expression of HCN1 and HCN4  and Popdc1 and Popdc2 . Thus, adrenergic control of the cardiac pacemaking and conduction may in particular be regulated via HCN channels and Popdc proteins. However, both PKA and EPAC also have their inputs in particular by modulating calcium release from the SR through the RyR2  and calcium uptake through phosphorylation of PLB .
We probably need to consider that the evaluation of gene function by knockout approaches alone has its limitation when confronted with a complex network of protein families with redundant and overlapping functions. In case of Popdc proteins, we have, on the one hand, functional redundancy due to the presence of three Popdc proteins with overlapping expression pattern and similar if not identical functions . In addition, however, there is also overlap in function at the level of the different cAMP effector proteins. Thus chronotropism of the cardiac pacemaker may involve the simultaneous activation of all four cAMP-binding proteins and therefore the loss of a single gene in one of the cAMP effector classes is compensated to a large extent by the remaining protein network.
However, if this assumption is correct, why vertebrates have maintained the same number of Popdc genes? An accidental loss of a gene encoding one of the mediator genes would be largely compensated and should be without severe consequences. A possible answer to this question might be that the heart has a vital role for a successful completion of the fight or flight response. Possibly, the speed with which the system can respond is key to the specific roles of Popdc proteins. Speed is undoubtedly an essential determinant of success in the fight or flight response. Since Popdc proteins have a high affinity for cAMP and are abundantly present in cardiac cells makes them ideally suited to mediate a rapid response to rising cAMP levels .
Thus in addition to the characterization of different animal models with a gain- and loss-of-Popdc gene function, it will be important to identify also small molecules, which are specific to the different cAMP effector proteins. These will assist in determining the specific functions of each cAMP effector protein. Such agonists and antagonists already exists for PKA , EPAC  and were recently discovered also for HCN channels . Such small molecules represent important tools for advancing our knowledge of the different functions of the various cAMP effector proteins and would in particular advance our knowledge of the function of Popdc proteins in the heart.
The authors acknowledge the funding of Medical Research council (MR/J010383/1) and The Magdi Yacoub Institute.
Conflicts of Interest
The authors declare no conflict of interest.
- Patel, T.B.; Du, Z.; Pierre, S.; Cartin, L.; Scholich, K. Molecular biological approaches to unravel adenylyl cyclase signaling and function. Gene 2001, 269, 13–25, doi:10.1016/S0378-1119(01)00448-6.
- Chen, J.; Levin, L.R.; Buck, J. Role of soluble adenylyl cyclase in the heart. Am. J. Physiol. Heart Circ. Physiol. 2012, 302, H538–H543, doi:10.1152/ajpheart.00701.2011.
- Rehmann, H.; Wittinghofer, A.; Bos, J.L. Capturing cyclic nucleotides in action: Snapshots from crystallographic studies. Nat. Rev. Mol. Cell. Biol. 2007, 8, 63–73, doi:10.1038/nrm2082.
- Froese, A.; Breher, S.S.; Waldeyer, C.; Schindler, R.F.; Nikolaev, V.O.; Rinne, S.; Wischmeyer, E.; Schlueter, J.; Becher, J.; Simrick, S.; et al. Popeye domain containing proteins are essential for stress-mediated modulation of cardiac pacemaking in mice. J. Clin. Invest. 2012, 122, 1119–1130, doi:10.1172/JCI59410.
- Schindler, R.F.; Poon, K.L.; Simrick, S.; Brand, T. The Popeye domain containing genes: Essential elements in heart rate control. Cardiovasc. Diagn. Ther. 2012, 2, 308–319. 24282731
- Brand, T.; Simrick, S.L.; Poon, K.L.; Schindler, R.F. The cAMP-binding Popdc proteins have a redundant function in the heart. Biochem. Soc. Transact. 2014, 42, 295–301, doi:10.1042/BST20130264.
- Simrick, S.; Schindler, R.F.; Poon, K.L.; Brand, T. Popeye domain-containing proteins and stress-mediated modulation of cardiac pacemaking. Trends Cardiovasc. Med. 2013, 23, 257–263, doi:10.1016/j.tcm.2013.02.002.
- Krahling, A.M.; Alvarez, L.; Debowski, K.; Van, Q.; Gunkel, M.; Irsen, S.; Al-Amoudi, A.; Strunker, T.; Kremmer, E.; Krause, E.; et al. CRIS-a novel cAMP-binding protein controlling spermiogenesis and the development of flagellar bending. PLoS Genet. 2013, 9, e1003960, doi:10.1371/journal.pgen.1003960.
- Reese, D.E.; Zavaljevski, M.; Streiff, N.L.; Bader, D. bves: A novel gene expressed during coronary blood vessel development. Dev. Biol. 1999, 209, 159–171, doi:10.1006/dbio.1999.9246.
- Andree, B.; Hillemann, T.; Kessler-Icekson, G.; Schmitt-John, T.; Jockusch, H.; Arnold, H.H.; Brand, T. Isolation and characterization of the novel popeye gene family expressed in skeletal muscle and heart. Dev. Biol. 2000, 223, 371–382, doi:10.1006/dbio.2000.9751.
- Andrée, B.; Fleige, A.; Arnold, H.H.; Brand, T. Mouse Pop1 is required for muscle regeneration in adult skeletal muscle. Mol. Cell Biol. 2002, 22, 1504–1512, doi:10.1128/MCB.22.5.1504-1512.2002.
- Breher, S.S.; Mavridou, E.; Brenneis, C.; Froese, A.; Arnold, H.H.; Brand, T. Popeye domain containing gene 2 (Popdc2) is a myocyte-specific differentiation marker during chick heart development. Dev. Dyn. 2004, 229, 695–702, doi:10.1002/dvdy.20015.
- Froese, A.; Brand, T. Expression pattern of Popdc2 during mouse embryogenesis and in the adult. Dev. Dyn. 2008, 237, 780–787, doi:10.1002/dvdy.21431.
- Kirchmaier, B.C.; Poon, K.L.; Schwerte, T.; Huisken, J.; Winkler, C.; Jungblut, B.; Stainier, D.Y.; Brand, T. The Popeye domain containing 2 (popdc2) gene in zebrafish is required for heart and skeletal muscle development. Dev. Biol. 2012, 363, 438–450, doi:10.1016/j.ydbio.2012.01.015.
- Hitz, M.P.; Pandur, P.; Brand, T.; Kuhl, M. Cardiac specific expression of Xenopus Popeye-1. Mech. Dev. 2002, 115, 123–126, doi:10.1016/S0925-4773(02)00085-0.
- Torlopp, A.; Breher, S.S.; Schluter, J.; Brand, T. Comparative analysis of mRNA and protein expression of Popdc1 (Bves) during early development in the chick embryo. Dev. Dyn. 2006, 235, 691–700, doi:10.1002/dvdy.20687.
- Gancedo, J.M. Biological roles of cAMP: Variations on a theme in the different kingdoms of life. Biol. Rev. Camb. Philos. Soc. 2013, 88, 645–668, doi:10.1111/brv.12020.
- Schindler, R.; Simrick, S.; Brand, T. Nuclear localization of members of popeye domain containing (Popdc) protein family. Cardiovas. Res. 2012, 93, S98.
- Alcalay, Y.; Hochhauser, E.; Kliminski, V.; Dick, J.; Zahalka, M.A.; Parnes, D.; Schlesinger, H.; Abassi, Z.; Shainberg, A.; Schindler, R.F.; et al. Popeye domain containing 1 (Popdc1/Bves) is a caveolae-associated protein involved in ischemia tolerance. PLoS One 2013, 8, e71100, doi:10.1371/journal.pone.0071100.
- Rodriguez, R.D.; Schocken, D.D. Update on sick sinus syndrome, a cardiac disorder of aging. Geriatrics 1990, 45, 26–30, 33–36. 2227459
- Gingold-Belfer, R.; Bergman, M.; Alcalay, Y.; Schlesinger, H.; Aravot, D.; Berman, M.; Salman, H.; Brand, T.; Kessler-Icekson, G. Popeye domain-containing 1 is down-regulated in failing human hearts. Int. J. Mol. Med. 2011, 27, 25–31. 21069264
- Honore, E. The neuronal background K2P channels: Focus on TREK1. Nat. Rev. Neurosci. 2007, 8, 251–261. 17375039
- Ogawa, T.; Forero, M.; Burgon, P.G.; Kuroski de Bold, M.L.; Georgalis, T.; de Bold, A.J. Role of potassium channels in stretch-promoted atrial natriuretic factor secretion. J. Am. Soc. Hypertens. 2009, 3, 9–18, doi:10.1016/j.jash.2008.07.002.
- Heurteaux, C.; Lucas, G.; Guy, N.; El Yacoubi, M.; Thummler, S.; Peng, X.D.; Noble, F.; Blondeau, N.; Widmann, C.; Borsotto, M.; et al. Deletion of the background potassium channel TREK-1 results in a depression-resistant phenotype. Nat. Neurosci. 2006, 9, 1134–1141, doi:10.1038/nn1749.
- Parton, R.G.; del Pozo, M.A. Caveolae as plasma membrane sensors, protectors and organizers. Nat. Rev. Mol. Cell. Biol. 2013, 14, 98–112, doi:10.1038/nrm3512.
- Hansen, C.G.; Nichols, B.J. Exploring the caves: Cavins, caveolins and caveolae. Trends Cell Biol. 2010, 20, 177–186, doi:10.1016/j.tcb.2010.01.005.
- Harvey, R.D.; Calaghan, S.C. Caveolae create local signalling domains through their distinct protein content, lipid profile and morphology. J. Mol. Cell. Cardiol. 2012, 52, 366–375, doi:10.1016/j.yjmcc.2011.07.007.
- Wright, P.T.; Nikolaev, V.O.; O’Hara, T.; Diakonov, I.; Bhargava, A.; Tokar, S.; Schobesberger, S.; Shevchuk, A.I.; Sikkel, M.B.; Wilkinson, R.; et al. Caveolin-3 regulates compartmentation of cardiomyocyte beta2-adrenergic receptor-mediated cAMP signaling. J. Mol. Cell Cardiol. 2014, 67, 38–48, doi:10.1016/j.yjmcc.2013.12.003.
- Balijepalli, R.C.; Kamp, T.J. Caveolae, ion channels and cardiac arrhythmias. Prog. Biophys. Mol. Biol. 2008, 98, 149–160, doi:10.1016/j.pbiomolbio.2009.01.012.
- Taylor, S.S.; Ilouz, R.; Zhang, P.; Kornev, A.P. Assembly of allosteric macromolecular switches: Lessons from PKA. Nat. Rev. Mol. Cell Biol. 2012, 13, 646–658, doi:10.1038/nrm3432.
- Rapundalo, S.T. Cardiac protein phosphorylation: Functional and pathophysiological correlates. Cardiovasc. Res. 1998, 38, 559–588, doi:10.1016/S0008-6363(98)00063-7.
- Maltsev, V.A.; Lakatta, E.G. Synergism of coupled subsarcolemmal Ca2+ clocks and sarcolemmal voltage clocks confers robust and flexible pacemaker function in a novel pacemaker cell model. Am. J. Physiol. Heart Circ. Physiol. 2009, 296, H594–H615, doi:10.1152/ajpheart.01118.2008.
- Vinogradova, T.M.; Lyashkov, A.E.; Zhu, W.; Ruknudin, A.M.; Sirenko, S.; Yang, D.; Deo, S.; Barlow, M.; Johnson, S.; Caffrey, J.L.; et al. High basal protein kinase A-dependent phosphorylation drives rhythmic internal Ca2+ store oscillations and spontaneous beating of cardiac pacemaker cells. Circ. Res. 2006, 98, 505–514, doi:10.1161/01.RES.0000204575.94040.d1.
- Ha, C.H.; Kim, J.Y.; Zhao, J.; Wang, W.; Jhun, B.S.; Wong, C.; Jin, Z.G. PKA phosphorylates histone deacetylase 5 and prevents its nuclear export, leading to the inhibition of gene transcription and cardiomyocyte hypertrophy. Proc. Natl. Acad. Sci. USA 2010, 107, 15467–15472, doi:10.1073/pnas.1000462107. 20716686
- Haj Slimane, Z.; Bedioune, I.; Lechene, P.; Varin, A.; Lefebvre, F.; Mateo, P.; Domergue-Dupont, V.; Dewenter, M.; Richter, W.; Conti, M.; et al. Control of cytoplasmic and nuclear protein kinase A by phosphodiesterases and phosphatases in cardiac myocytes. Cardiovasc. Res. 2014, 102, 97–106, doi:10.1093/cvr/cvu029.
- Backs, J.; Worst, B.C.; Lehmann, L.H.; Patrick, D.M.; Jebessa, Z.; Kreusser, M.M.; Sun, Q.; Chen, L.; Heft, C.; Katus, H.A.; et al. Selective repression of MEF2 activity by PKA-dependent proteolysis of HDAC4. J. Cell. Biol. 2011, 195, 403–415, doi:10.1083/jcb.201105063.
- Diviani, D.; Dodge-Kafka, K.L.; Li, J.; Kapiloff, M.S. A-kinase anchoring proteins: Scaffolding proteins in the heart. Am. J. Physiol. Heart Circ. Physiol. 2011, 301, H1742–H1753, doi:10.1152/ajpheart.00569.2011.
- Scott, J.D.; Santana, L.F. A-kinase anchoring proteins: Getting to the heart of the matter. Circulation 2010, 121, 1264–1271, doi:10.1161/CIRCULATIONAHA.109.896357.
- Bisserier, M.; Blondeau, J.P.; Lezoualc’h, F. Epac proteins: Specific ligands and role in cardiac remodelling. Bioch. Soc. Trans. 2014, 42, 257–264, doi:10.1042/BST20140033.
- De Rooij, J.; Zwartkruis, F.J.; Verheijen, M.H.; Cool, R.H.; Nijman, S.M.; Wittinghofer, A.; Bos, J.L. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 1998, 396, 474–477, doi:10.1038/24884.
- Kawasaki, H.; Springett, G.M.; Mochizuki, N.; Toki, S.; Nakaya, M.; Matsuda, M.; Housman, D.E.; Graybiel, A.M. A family of cAMP-binding proteins that directly activate Rap1. Science 1998, 282, 2275–2279, doi:10.1126/science.282.5397.2275.
- Morel, E.; Marcantoni, A.; Gastineau, M.; Birkedal, R.; Rochais, F.; Garnier, A.; Lompre, A.M.; Vandecasteele, G.; Lezoualc’h, F. cAMP-binding protein Epac induces cardiomyocyte hypertrophy. Circ. Res. 2005, 97, 1296–1304, doi:10.1161/01.RES.0000194325.31359.86.
- Hothi, S.S.; Gurung, I.S.; Heathcote, J.C.; Zhang, Y.; Booth, S.W.; Skepper, J.N.; Grace, A.A.; Huang, C.L. Epac activation, altered calcium homeostasis and ventricular arrhythmogenesis in the murine heart. Pflugers Arch. 2008, 457, 253–270, doi:10.1007/s00424-008-0508-3.
- Pereira, L.; Metrich, M.; Fernandez-Velasco, M.; Lucas, A.; Leroy, J.; Perrier, R.; Morel, E.; Fischmeister, R.; Richard, S.; Benitah, J.P.; et al. The cAMP binding protein Epac modulates Ca2+ sparks by a Ca2+/calmodulin kinase signalling pathway in rat cardiac myocytes. J. Physiol. 2007, 583, 685–694, doi:10.1113/jphysiol.2007.133066.
- Pereira, L.; Cheng, H.; Lao, D.H.; Na, L.; van Oort, R.J.; Brown, J.H.; Wehrens, X.H.; Chen, J.; Bers, D.M. Epac2 mediates cardiac beta1-adrenergic-dependent sarcoplasmic reticulum Ca2+ leak and arrhythmia. Circulation 2013, 127, 913–922, doi:10.1161/CIRCULATIONAHA.12.148619.
- Somekawa, S.; Fukuhara, S.; Nakaoka, Y.; Fujita, H.; Saito, Y.; Mochizuki, N. Enhanced functional gap junction neoformation by protein kinase A-dependent and Epac-dependent signals downstream of cAMP in cardiac myocytes. Circ. Res. 2005, 97, 655–662, doi:10.1161/01.RES.0000183880.49270.f9.
- Metrich, M.; Lucas, A.; Gastineau, M.; Samuel, J.L.; Heymes, C.; Morel, E.; Lezoualc’h, F. Epac mediates beta-adrenergic receptor-induced cardiomyocyte hypertrophy. Circ. Res. 2008, 102, 959–965, doi:10.1161/CIRCRESAHA.107.164947.
- Metrich, M.; Laurent, A.C.; Breckler, M.; Duquesnes, N.; Hmitou, I.; Courillau, D.; Blondeau, J.P.; Crozatier, B.; Lezoualc’h, F.; Morel, E. Epac activation induces histone deacetylase nuclear export via a Ras-dependent signalling pathway. Cell Signal. 2010, 22, 1459–1468, doi:10.1016/j.cellsig.2010.05.014.
- DiFrancesco, D. The role of the funny current in pacemaker activity. Circ. Res. 2010, 106, 434–446, doi:10.1161/CIRCRESAHA.109.208041.
- Lakatta, E.G.; Maltsev, V.A.; Vinogradova, T.M. A coupled SYSTEM of intracellular Ca2+ clocks and surface membrane voltage clocks controls the timekeeping mechanism of the heart’s pacemaker. Circ. Res. 2010, 106, 659–673, doi:10.1161/CIRCRESAHA.109.206078.
- Herrmann, S.; Layh, B.; Ludwig, A. Novel insights into the distribution of cardiac HCN channels: An expression study in the mouse heart. J. Mol. Cell Cardiol. 2011, 51, 997–1006, doi:10.1016/j.yjmcc.2011.09.005.
- Ludwig, A.; Budde, T.; Stieber, J.; Moosmang, S.; Wahl, C.; Holthoff, K.; Langebartels, A.; Wotjak, C.; Munsch, T.; Zong, X.; et al. Absence epilepsy and sinus dysrhythmia in mice lacking the pacemaker channel HCN2. EMBO J. 2003, 22, 216–224, doi:10.1093/emboj/cdg032.
- Baruscotti, M.; Bucchi, A.; Viscomi, C.; Mandelli, G.; Consalez, G.; Gnecchi-Rusconi, T.; Montano, N.; Casali, K.R.; Micheloni, S.; Barbuti, A.; et al. Deep bradycardia and heart block caused by inducible cardiac-specific knockout of the pacemaker channel gene Hcn4. Proc. Natl. Acad. Sci. USA 2011, 108, 1705–1710, doi:10.1073/pnas.1010122108.
- Fenske, S.; Krause, S.C.; Hassan, S.I.; Becirovic, E.; Auer, F.; Bernard, R.; Kupatt, C.; Lange, P.; Ziegler, T.; Wotjak, C.T.; et al. Sick sinus syndrome in HCN1-deficient mice. Circulation 2013, 128, 2585–2594, doi:10.1161/CIRCULATIONAHA.113.003712.
- Herrmann, S.; Stieber, J.; Stockl, G.; Hofmann, F.; Ludwig, A. HCN4 provides a ‘depolarization reserve’ and is not required for heart rate acceleration in mice. EMBO J. 2007, 26, 4423–4432, doi:10.1038/sj.emboj.7601868.
- Stieber, J.; Herrmann, S.; Feil, S.; Loster, J.; Feil, R.; Biel, M.; Hofmann, F.; Ludwig, A. The hyperpolarization-activated channel HCN4 is required for the generation of pacemaker action potentials in the embryonic heart. Proc. Natl. Acad. Sci. USA 2003, 100, 15235–15240, doi:10.1073/pnas.2434235100.
- Bucchi, A.; Baruscotti, M.; Nardini, M.; Barbuti, A.; Micheloni, S.; Bolognesi, M.; DiFrancesco, D. Identification of the molecular site of ivabradine binding to HCN4 channels. PLoS ONE 2013, 8, doi:10.1371/journal.pone.0053132.
- Sargento, L.; Satendra, M.; Longo, S.; Lousada, N.; Dos Reis, R.P. Heart rate reduction with ivabradine in patients with acute decompensated heart failure. Am. J. Cardiovasc. Drugs 2014. in press.
- Wainger, B.J.; DeGennaro, M.; Santoro, B.; Siegelbaum, S.A.; Tibbs, G.R. Molecular mechanism of cAMP modulation of HCN pacemaker channels. Nature 2001, 411, 805–810, doi:10.1038/35081088.
- Alig, J.; Marger, L.; Mesirca, P.; Ehmke, H.; Mangoni, M.E.; Isbrandt, D. Control of heart rate by cAMP sensitivity of HCN channels. Proc. Natl. Acad. Sci. USA 2009, 106, 12189–12194, doi:10.1073/pnas.0810332106.
- Harzheim, D.; Pfeiffer, K.H.; Fabritz, L.; Kremmer, E.; Buch, T.; Waisman, A.; Kirchhof, P.; Kaupp, U.B.; Seifert, R. Cardiac pacemaker function of HCN4 channels in mice is confined to embryonic development and requires cyclic AMP. EMBO J. 2008, 27, 692–703, doi:10.1038/emboj.2008.3.
- Schulze-Bahr, E.; Neu, A.; Friederich, P.; Kaupp, U.B.; Breithardt, G.; Pongs, O.; Isbrandt, D. Pacemaker channel dysfunction in a patient with sinus node disease. J. Clin. Invest. 2003, 111, 1537–1545, doi:10.1172/JCI200316387.
- Schweizer, P.A.; Duhme, N.; Thomas, D.; Becker, R.; Zehelein, J.; Draguhn, A.; Bruehl, C.; Katus, H.A.; Koenen, M. cAMP sensitivity of HCN pacemaker channels determines basal heart rate but is not critical for autonomic rate control. Circ. Arrhythm. Electrophysiol. 2010, 3, 542–552, doi:10.1161/CIRCEP.110.949768.
- Liao, Z.; Lockhead, D.; Larson, E.D.; Proenza, C. Phosphorylation and modulation of hyperpolarization-activated HCN4 channels by protein kinase A in the mouse sinoatrial node. J. Gen. Physiol. 2010, 136, 247–258, doi:10.1085/jgp.201010488.
- Gjertsen, B.T.; Mellgren, G.; Otten, A.; Maronde, E.; Genieser, H.G.; Jastorff, B.; Vintermyr, O.K.; McKnight, G.S.; Doskeland, S.O. Novel (Rp)-cAMPS analogs as tools for inhibition of cAMP-kinase in cell culture. Basal cAMP-kinase activity modulates interleukin-1 beta action. J. Biol. Chem. 1995, 270, 20599–20607, doi:10.1074/jbc.270.35.20599.
- Enserink, J.M.; Christensen, A.E.; de Rooij, J.; van Triest, M.; Schwede, F.; Genieser, H.G.; Doskeland, S.O.; Blank, J.L.; Bos, J.L. A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat. Cell Biol. 2002, 4, 901–906, doi:10.1038/ncb874.
- Moller, S.; Alfieri, A.; Bertinetti, D.; Aquila, M.; Schwede, F.; Lolicato, M.; Rehmann, H.; Moroni, A.; Herberg, F.W. Cyclic nucleotide mapping of hyperpolarization-activated cyclic nucleotide-gated (HCN) channels. ACS Chem. Biol. 2014, doi:10.1021/cb400904s.
© 2014 by the authors; licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution license (http://creativecommons.org/licenses/by/3.0/).